<VariationArchive VariationID="1777" VariationName="NM_000102.4(CYP17A1):c.1435_1438dup (p.Pro480fs)" VariationType="Duplication" Accession="VCV000001777" Version="25" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-06-17" DateCreated="2015-05-08" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="16816" VariationID="1777">
      <GeneList>
        <Gene Symbol="CYP17A1" FullName="cytochrome P450 family 17 subfamily A member 1" GeneID="1586" HGNC_ID="HGNC:2593" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q24.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102830531" stop="102837413" display_start="102830531" display_stop="102837413" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="104590287" stop="104597289" display_start="104590287" display_stop="104597289" Strand="-" />
          </Location>
          <OMIM>609300</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000102.4(CYP17A1):c.1435_1438dup (p.Pro480fs)</Name>
      <CanonicalSPDI>NC_000010.11:102830790:GGATG:GGATGGATG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q24.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102830790" stop="102830791" display_start="102830790" display_stop="102830791" variantLength="4" positionVCF="102830790" referenceAlleleVCF="G" alternateAlleleVCF="GGGAT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="104590547" stop="104590548" display_start="104590547" display_stop="104590548" variantLength="4" positionVCF="104590547" referenceAlleleVCF="G" alternateAlleleVCF="GGGAT" />
      </Location>
      <OtherNameList>
        <Name>p.Pro480HisfsX27</Name>
      </OtherNameList>
      <ProteinChange>P480fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.104590549_104590552dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.104590549_104590552dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.102830792_102830795dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.102830792_102830795dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007955.1" sequenceAccession="NG_007955" sequenceVersion="1" change="g.11740_11743dup">
            <Expression>NG_007955.1:g.11740_11743dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000102.4" sequenceAccession="NM_000102" sequenceVersion="4" change="c.1435_1438dup" MANESelect="true">
            <Expression>NM_000102.4:c.1435_1438dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000093.1" sequenceAccession="NP_000093" sequenceVersion="1" change="p.Pro480fs">
            <Expression>NP_000093.1:p.Pro480fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000102.3" sequenceAccession="NM_000102" sequenceVersion="3" change="c.1435_1438dup">
            <Expression>NM_000102.3:c.1435_1438dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA212780" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="609300.0001" DB="OMIM" />
        <XRef Type="rs" ID="556794126" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000102.4(CYP17A1):c.1435_1438dup (p.Pro480fs) AND 17-alpha-hydroxylase/17,20-lyase deficiency, combined complete" Accession="RCV000001849" Version="3">
        <ClassifiedConditionList TraitSetID="457">
          <ClassifiedCondition DB="MedGen" ID="CN042980">17-alpha-hydroxylase/17,20-lyase deficiency, combined complete</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1992-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000102.4(CYP17A1):c.1435_1438dup (p.Pro480fs) AND not provided" Accession="RCV000498913" Version="11">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000102.4(CYP17A1):c.1435_1438dup (p.Pro480fs) AND Deficiency of steroid 17-alpha-monooxygenase" Accession="RCV000337017" Version="13">
        <ClassifiedConditionList TraitSetID="6417">
          <ClassifiedCondition DB="MedGen" ID="C0268285">Deficiency of steroid 17-alpha-monooxygenase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-06-11" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000102.4(CYP17A1):c.1435_1438dup (p.Pro480fs) AND Congenital adrenal hyperplasia" Accession="RCV002271363" Version="1">
        <ClassifiedConditionList TraitSetID="8584">
          <ClassifiedCondition DB="MedGen" ID="C0001627">Congenital adrenal hyperplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-06-11" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2015-05-08" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15771555</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1577471</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2493025</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2786493</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2843762</ID>
        </Citation>
        <DescriptionHistory Dated="2024-06-13">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-05-24">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2016-12-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6417" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="185" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">17-alpha-hydroxylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency</ElementValue>
                <XRef ID="MONDO:0008730" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital adrenal hyperplasia type 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPERPLASIA V</ElementValue>
                <XRef Type="MIM" ID="202110" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of steroid 17-alpha-monooxygenase</ElementValue>
                <XRef ID="124220008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">17-alpha-hydroxylase/17,20-lyase deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1469" />
                <XRef ID="1469" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="90793" DB="Orphanet" />
              <XRef ID="C0268285" DB="MedGen" />
              <XRef ID="MONDO:0008730" DB="MONDO" />
              <XRef Type="MIM" ID="202110" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8584" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6254" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hyperplasia</ElementValue>
                <XRef ID="HP:0008258" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0018479" DB="MONDO" />
                <XRef ID="237751000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CAH</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1467" />
                <XRef ID="1467" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2018">
                <URL>https://www.acmg.net/PDFLibrary/CAH-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics ACT SHEET, Transition to Adult Health Care ACT Sheet, Congenital Adrenal Hyperplasia (CAH)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/Elevated-17-OHP-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Congenital Adrenal Hyperplasia (Elevated 17-OHP), 2009</CitationText>
              </Citation>
              <XRef ID="418" DB="Orphanet" />
              <XRef ID="C0001627" DB="MedGen" />
              <XRef ID="MONDO:0018479" DB="MONDO" />
              <XRef Type="primary" ID="HP:0008258" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="457" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8871" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">17-alpha-hydroxylase/17,20-lyase deficiency, combined complete</ElementValue>
                <XRef ID="MONDO:0800379" DB="MONDO" />
              </Name>
              <XRef ID="CN042980" DB="MedGen" />
              <XRef ID="MONDO:0800379" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="22005" SubmissionDate="2015-04-30" DateLastUpdated="2015-05-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="609300.0001_17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE" title="CYP17A1, 4-BP DUP, EX8_17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE" />
        <ClinVarAccession Accession="SCV000022005" DateUpdated="2015-05-08" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1992-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with combined 17-alpha-hydroxylase/17,20-lyase deficiency (202110), Kagimoto et al. (1988) demonstrated a 4-base duplication in exon 8 of the CYP17A1 gene. The resultant protein had an altered C-terminal amino acid sequence which resulted in loss of both enzymatic activities. This mutation was also found in affected members of 2 presumably unrelated Canadian Mennonite families (Kagimoto et al., 1989).</Attribute>
              <Citation>
                <ID Source="PubMed">2843762</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2786493</ID>
              </Citation>
              <XRef DB="OMIM" ID="202110" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Imai et al. (1992) identified the CYP17A1 4-bp duplication in affected members of 6 families residing in the Friesland region of the Netherlands. Since the Mennonite sect derives its name from Menno Simons, the founder of the group in Friesland in the 16th century, the 4-bp duplication presumably appeared within the population before the migration of the Mennonites from the Netherlands to Canada.</Attribute>
              <Citation>
                <ID Source="PubMed">1577471</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP17A1" />
          </GeneList>
          <Name>CYP17A1, 4-BP DUP, EX8</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DUP, EX8</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609300.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1894790" SubmissionDate="2019-03-21" DateLastUpdated="2019-08-26" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="90752485|Orphanet:ORPHA90793" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000966996" DateUpdated="2019-08-26" DateCreated="2019-08-26" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1577471</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2843762</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2786493</ID>
          </Citation>
          <Comment>The p.Pro480HisfsX27 variant in CYP17A1 has been reported in 7 individuals with 17 alpha-hydroxylase/17,20-lyase deficiency and segregated with disease in 2 aff ected family members from 2 families (Kagimoto 1988, Kagimoto 1989, Imai 1992). It has also been identified in 5/104972 of European chromosomes by gnomAD (http: //gnomad.broadinstitute.org). This variant is predicted to cause a frameshift, w hich alters the protein?s amino acid sequence beginning at position 480 and lead s to a premature termination codon 27 amino acids downstream. This termination c odon occurs within the terminal 50 bases of the second to the last exon and is t herefore likely to escape nonsense mediated decay (NMD) and result in a truncate d protein. In summary, although additional studies are required to fully establi sh its clinical significance, the p.Pro480HisfsX27 variant is likely pathogenic. ACMG/AMP criteria applied: PM2, PM3, PVS1_Moderate, PP1_Moderate.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP17A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000102.3:EXON 8</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_000102.3:c.1435_1438dupATCC</Name>
            <Name>p.Pro480HisfsX27</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.104590547_104590548insGGAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Deficiency of steroid 17-alpha-monooxygenase</ElementValue>
            </Name>
            <XRef DB="Orphanet" ID="ORPHA90793" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348959</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3430041" SubmissionDate="2021-09-02" DateLastUpdated="2021-09-08" DateCreated="2021-07-07">
        <ClinVarSubmissionID localKey=":Chr.10_104590547_104590547_G_GGGAT|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001742048" DateUpdated="2021-09-08" DateCreated="2021-07-07" Type="SCV" Version="3" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" OrgID="506382" OrganizationCategory="laboratory" OrgAbbreviation="DL-UMCG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP17A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="GGGAT" referenceAllele="G" start="104590547" stop="104590547" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <StudyDescription>VKGL Data-share Consensus</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB10172767</SubmissionName>
          <SubmissionName>SUB10306554</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5001077" SubmissionDate="2022-07-29" DateLastUpdated="2022-08-03" DateCreated="2022-08-03">
        <ClinVarSubmissionID localKey="NM_000102.3:c.1435_1438dupATCC|MedGen:C0001627" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002555791" DateUpdated="2022-08-03" DateCreated="2022-08-03" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2786493</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2843762</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15771555</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2493025</ID>
          </Citation>
          <Comment>Variant summary: CYP17A1 c.1435_1438dupATCC (p.Pro480HisfsX27) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2.5e-05 in 237994 control chromosomes. c.1435_1438dupATCC has been reported in the literature in multiple individuals affected with Congenital Adrenal Hyperplasia (example Kagimoto_1988, Kagimoto-1989, Perez_2004). These data indicate that the variant is very likely to be associated with disease. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation.Two laboratories classified the variant as pathogenic, one as likely pathogenic, and one classified it VUS. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP17A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000102.3:c.1435_1438dupATCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0001627" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11876943</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="673660" SubmissionDate="2024-06-11" DateLastUpdated="2024-06-17" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey=":Chr.10_104590547_G_GGGAT|MedGen:C0268285" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000360138" DateUpdated="2024-06-17" DateCreated="2016-12-06" Type="SCV" Version="4" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-06-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSLVariantClassificationCriteria RUGD 01 April 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/dy7elfgy/icslvariantclassificationcriteria_rugd_01_april_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="GGGAT" referenceAllele="G" start="104590547" stop="104590547" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268285" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14525850</SubmissionName>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7867489" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000102.4:c.1435_1438dup|OMIM:202110" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004215388" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000102.4:c.1435_1438dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="202110" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1143252" SubmissionDate="2019-01-29" DateLastUpdated="2017-08-20" DateCreated="2017-08-20">
        <ClinVarSubmissionID localKey="GDX:708484|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000589608" DateUpdated="2017-08-20" DateCreated="2017-08-20" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1435_1438dupATCC variant has been reported previously in the homozygous state in association with 17 alpha-hydroxylase/17,20-lyase deficiency (Kagimoto et al., 1988; Kagimoto et al., 1989; Imai et al., 1992). The duplication causes a frameshift starting with codon Proline 480, changes this amino acid to a Histidine residue and creates a premature Stop codon at position 27 of the new reading frame, denoted p.Pro480HisfsX27. This variant is predicted to cause loss of normal protein function through protein truncation. The variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). In summary, we consider this variant to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP17A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="GGATGGAT" referenceAllele="GGAT" start="104590546" stop="104590547" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000102.3:c.1435_1438dupATCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3549541" SubmissionDate="2021-08-24" DateLastUpdated="2021-08-25" DateCreated="2021-08-25">
        <ClinVarSubmissionID localKey=":Chr.10_104590547_104590547_G_GGGAT|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001809623" DateUpdated="2021-08-25" DateCreated="2021-08-25" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, Amsterdam University Medical Center" OrgID="506453" OrganizationCategory="laboratory" OrgAbbreviation="VUMC GD" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP17A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="GGGAT" referenceAllele="G" start="104590547" stop="104590547" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10240015</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3870967" SubmissionDate="2021-10-15" DateLastUpdated="2021-10-16" DateCreated="2021-10-16">
        <ClinVarSubmissionID localKey=":Chr.10_104590547_104590547_G_GGGAT|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001980160" DateUpdated="2021-10-16" DateCreated="2021-10-16" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP17A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="GGGAT" referenceAllele="G" start="104590547" stop="104590547" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10520787</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1850651" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4782288|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000956427" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1577471</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2786493</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro480Hisfs*27) in the CYP17A1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 29 amino acid(s) of the CYP17A1 protein. This variant is present in population databases (rs556794126, gnomAD 0.005%). This premature translational stop signal has been observed in individuals with congenital adrenal hyperplasia (PMID: 1577471, 2786493). ClinVar contains an entry for this variant (Variation ID: 1777). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP17A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.104590547_104590548insGGAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5001077" TraitType="Disease" MappingType="XRef" MappingValue="C0001627" MappingRef="MedGen">
        <MedGen CUI="C0001627" Name="Congenital adrenal hyperplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3870967" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7867489" TraitType="Disease" MappingType="XRef" MappingValue="202110" MappingRef="OMIM">
        <MedGen CUI="C0268285" Name="Deficiency of steroid 17-alpha-monooxygenase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="673660" TraitType="Disease" MappingType="XRef" MappingValue="C0268285" MappingRef="MedGen">
        <MedGen CUI="C0268285" Name="Deficiency of steroid 17-alpha-monooxygenase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1894790" TraitType="Disease" MappingType="Name" MappingValue="Deficiency of steroid 17-alpha-monooxygenase" MappingRef="Preferred">
        <MedGen CUI="C0268285" Name="Deficiency of steroid 17-alpha-monooxygenase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3549541" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1850651" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3430041" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1143252" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

